Table 2.
Characteristics of the included clinical practice guidelines
| Title of CPGs | Abbreviated Name | Development institution | Continent/Country | Year Published/Updated | Newly developed | Publication in a journal | Evidence analysis | Quality tool referral | |
|---|---|---|---|---|---|---|---|---|---|
| Journal name | Impact factor (2022) | ||||||||
| 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy | AHA/ACC HCM (2020) | AHA/ACC | USA | 2020 | No | Journal of the American College of Cardiology | 24.4 | Systematic review, consensus method among experts, including a lay/patient representative | AHA/ACC Policies for Development of Guidelines, Performance Measures, and Data Standards, Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines |
| 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease | AHA/ACC PAD (2016) | AHA/ACC | USA | 2017 | No | Circulation, Co-published in the Journal of the American College of Cardiology and reprinted in Vascular Medicine |
- Circulation: 37.8 - Journal of the American College of Cardiology:24.4 - Vascular Medicine:3.7 |
Systematic literature review, a nurse in the role of patient representative in the writing committee | Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines |
| 2022 AHA ACC HFSA Guideline for the Management of Heart Failure | AHA/ACC/HFSA HF (2022) | AHA ACC HFSA | USA | 2022 | No | Circulation | 37.8 | Systematic literature review, 2 lay/patient representatives in the writing committee | Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines |
| 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation | AHA/ACC/HRS AF (2019) | AHA ACC HRS | USA | 2019 | No | Journal of the American College of Cardiology, co-published in Circulation and Heart Rhythm |
- Journal of the American College of Cardiology:24.4 - Circulation: 37.8 |
Systematic review | Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines |
| 2021 AHA ASA Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack | AHA/ASA Stroke (2021) | AHA ASA | USA | 2021 | No | Stroke | 8.3 | Systematic Review, consensus method among experts, a lay/patient representative in the writing group | AHA/ASA Policies and Procedures for Development of Scientific Publications |
| 2018 Australian Guidelines for the Prevention, Detection, and Management of Heart Failure | Australia HF (2018) | NHFA CSANZ | Australia | 2018 | No | Heart, Lung and Circulation | 2.6 | Systematic literature review | Not reported |
| 2019 Brazilian CVDs prevention guideline 2019 update | Brazilian CVD (2019) | SBC | Brazil | 2019 | No | Arq Bras Cardiol | 2.6 | Systematic literature review | Not reported |
| 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure | Canadian HF (2017) | CCS | Canada | 2017 | No | Canadian Journal of Cardiology | 7.2 | Systematic literature review | AGREE II |
| 2020 Canadian Stroke Best Practice Recommendations Secondary Prevention of Stroke Update 2020 | CSBPR (2020) | HSF Canada | Canada | 2020 | No | No | NA | Systematic review, consensus method among experts | AGREE II |
| 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) | ESC AF (2020) | ESC EACTS | Europe | 2020 | No | European Heart Journal | 39.3 | Systematic review, consensus method among experts | ESC Recommendations for Guidelines Production |
| 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice | ESC CVD (2021) | ESC | Europe | 2021 | No | European Heart Journal | 39.3 | Systematic literature review | ESC Recommendations for Guidelines Production |
| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure | ESC HF (2021) | ESC | Europe | 2021 | No | European Heart Journal | 39.3 | Systematic literature review | ESC Recommendations for Guidelines Production |
| 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases in collaboration with the European Society for Vascular Surgery (ESVS) | ESC PAD (2017) | ESC ESVS | Europe | 2018 | No | European Heart Journal | 39.3 | Systematic literature review | ESC Recommendations for Guidelines Production |
| ESVM (European Journal of Vascular Medicine) Guideline on peripheral arterial disease 2019 | ESVM PAD (2019) | ESVM | Europe | 2019 | No | Vasa-European Journal of Vascular Medicine | 1.8 | Systematic literature review, consensus method among experts | Not reported |
| JCS 2017 JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure | JCS /JHFS HF (2017) | JCS JHFS | Japan | 2017 | No | Circulation Journal | 3.3 | Systematic literature Review | Not reported |
| 2019 Korean Clinical Practice Guideline for Cardiac Rehabilitation in Korea Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome | Korean CR ACS (2019) | The Korean Society of Cardiology | Korea | 2019 | Yes | Korean Circulation Journal | 2.9 | Systematic review | Not reported |
| 2018 Malaysian clinical practice guidelines of stable coronary artery disease | Malaysia SCAD (2018) | NHAM AMM | Malaysia | 2018 | No | No | NA | Systematic literature review, consensus method among experts | Not reported |
| 2019 Malaysian clinical practice guidelines management of STEMI | Malaysia STEMI (2019) | NHAM AMM | Malaysia | 2019 | No | No | NA | Systematic literature review, consensus method among experts | Not reported |
| 2017 Malaysian Primary & Secondary Prevention of Cardiovascular Disease | Malaysian CVD (2017) | NHAM AMM | Malaysia | 2017 | Yes | No | NA | Systematic literature review, consensus method among experts | Not reported |
| 2019 Malaysian clinical practice guidelines management of Heart Failure | Malaysian HF (2019) | NHAM AMM MOH Malaysia | Malaysia | 2019 | No | No | NA | Systematic literature review, consensus method among experts | Not reported |
| Physical Therapist Clinical Practice Guideline for the Management of Individuals with Heart Failure 2020 | PT HF (2020) | APTA | USA | 2020 | Yes | Physical therapy | 3.8 | Systematic literature review, the consensus among experts, including a patient representative as external reviewer | AGREE II |
| 2017 SIGN Risk estimation and the prevention of cardiovascular disease | SIGN 149 CVD (2017) | SIGN | UK | 2017 | No | No | NA | Systematic literature review | SIGN 50: a guideline developer’s handbook, 2015 edition |
| 2019 USA VADoD clinical practice guideline for the management of stroke rehabilitation | VA/DoD Stroke Rehab (2019) | VA/DoD | USA | 2019 | No | No | NA | Systematic review, consensus method among experts, including patient focus group | The Guideline for Guidelines, an internal document of the VA and DoD EBPWG2019 |
Note: AHA/ACC American Heart Association/American College of Cardiology, HFSA the Heart Failure Society of America, HRS Heart Rhythm Society, ASA American Stroke Association, ESC the European Society of Cardiology, EACTS the European Association for Cardio-Thoracic Surgery, ESVS the European Society for Vascular Surgery, ESVM European Society for Vascular Medicine, JCS the Japanese Circulation Society, JHFS the Japanese Heart Failure Society, NHAM National Heart Association of Malaysia, AMM the Academy of Medicine Malaysia, MOH Malaysia, Ministry of Health Malaysia, APTA The American Physical Therapy Association, SIGN Scottish Intercollegiate Guidelines Network, VA/DoD Department of Veterans Affairs, Department of Defense, CSANZ Cardiac Society of Australia and New Zealand, NHFA National Heart Foundation of Australia, HSF Canada Heart and Stroke Foundation of Canada, CCS Canadian Cardiovascular Society, SBC Brazilian Society of Cardiology, NA Not applicable, AGREE II Appraisal of Guidelines for Research & Evaluation II